| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 1.04 Billion |
| Market Size (2030) | USD 1.66 Billion |
| CAGR (2025 - 2030) | 9.73% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Asia-Pacific Respiratory Monitoring Market Analysis
The Asia-Pacific Respiratory Monitoring Market size is estimated at USD 1.04 billion in 2025, and is expected to reach USD 1.66 billion by 2030, at a CAGR of 9.73% during the forecast period (2025-2030).
- The COVID-19 pandemic had a significant impact on Asia-Pacific respiratory monitoring market. The pandemic unmasked the effect of health resource inequities and the lack of preparedness to upscale a coordinated response in many countries in the region. For instance, in May 2021, China exported over 15,000 patient monitors, to India, including respiratory monitors. Such a surge in demand drives the growth of the market.
- Additionally, as per the data published by the Australian Institute of Health and Welfare, in July 2022, the government spent USD 13.6 million through the National Partnership on COVID-19 Response (NPCR) to provide access to pulse oximeters to general practice and other healthcare settings to support the safe management of COVID-positive people. Hence, due to the surge in COVID-19 cases, the demand for respiratory monitoring devices increased, fuelling the market's growth. However, the market lost some traction as COVID-19 cases declined in the first three quarters, and the COVID-19 pandemic accelerated the use of respiratory devices. However, with the re-elevation of COVID-19 issues in China, the demand for respiratory monitoring is expected to create lucrative opportunities for the growth of the Asia-Pacific respiratory monitoring market in the studied period.
- The primary factors driving the market's growth include the high prevalence of respiratory diseases and growing pollution levels due to urbanization. For instance, according to the study published by the Journal of Infection and Chemotherapy in February 2022, respiratory syncytial virus (RSV) is one of the most common causes of lower respiratory tract infections in children of age five years and above in Japan and is associated with long-term respiratory morbidities such as recurrent wheezing and asthma, decreased lung function, and allergic sensitization. The respiratory syncytial virus imposes a significant burden on the Japanese healthcare system. Additionally, according to an article published in the International Journal of Chronic Obstructive Pulmonary Disease in October 2022, it was observed that 15.5 in 1,000 people were diagnosed with chronic obstructive pulmonary disease (COPD) annually in South Korea.
- In addition, as per the same source, the incidence rate of COPD was higher among men than women. Furthermore, according to a report published by the Global Asthma Network in 2022, asthma is one of the most common chronic diseases that affects about 262 million people globally, and it is a major cause of substantial burden of disease, including both premature death and reduced quality of life, in people of all ages in all parts of the world. Thus, the high prevalence of respiratory diseases, anticipated to increase the demand for different respiratory monitoring devices, which is expected to fuel the market growth over the forecast period.
- Additionally, the increasing initiatives such as product launches, acquisitions, and partnerships by market players in Asia-Pacific are also expected to contribute to the market's growth. For instance, in March 2021, Vyaire Medical launched the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries, including Australia and others. This new technology allows physicians to promptly diagnose pulmonary diseases, including asthma and COPD, as accurately as hospital-grade spirometers. It performs high-quality patient monitoring via advanced digital connectivity at home. Such development is expected to drive the market's growth over the forecast period.
- Hence, as to the factors mentioned above, such as the high prevalence of respiratory diseases and growing pollution levels due to urbanization, Asia-Pacific respiratory monitoring market is anticipated to grow over the forecast period. However, reimbursement concerns and high costs associated with the devices will likely restrain the market growth.
Asia-Pacific Respiratory Monitoring Market Trends
Pulse Oximeters Segment is Expected to Witness Growth Over the Forecast Period
- Pulse oximetry is a noninvasive method for monitoring a person's oxygen saturation. Pulse oximeters hold a significant market share due to the accurate reliability and speed of monitoring patients with respiratory diseases. The pulse oximeter is used to manage chronic obstructive pulmonary disease (COPD) and other lung conditions, likely promoting the market growth.
- For instance, as per the article published by the International Journal of Chronic Obstructive Pulmonary Disease, in September 2022, the prevalence of COPD in China was estimated as 13.7%, equating to approximately 99.9 million patients with COPD. Thus, the demand for pulse oximeters increases due to the high burden of respiratory disease, driving the market's growth.
- Additionally, the increasing initiatives such as product launches, acquisitions, and collaborations by the government and market players are also expected to contribute to the market's growth.
- For instance, in October 2022, GX Foundation launched a second phase of pulse oximeters distribution throughout the Hong Kong community. GX partnered with the Collaborating Centre for Oxford University and the Chinese University of Hong Kong for Disaster and Medical Humanitarian Response (CCOUC) to distribute pulse oximeters to 20 organizations. This enabled caregivers to provide home-based monitoring of older adults and COVID-19 patients, strengthen the independence and effectiveness of home-based care, and alleviate the burden on hospitals during difficult times.
- Such an initiative is expected to drive the market's growth over the forecast period. Hence, factors such as accurate reliability and speed of monitoring of patients are expected to drive pulse oximeter segment growth over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
India is Expected to Hold a Significant Share of the Market Over the Forecast Period
- India's respiratory monitoring market is expected to hold significant growth over the forecast period owing to factors such as the growing burden of respiratory disorders such as chronic obstructive pulmonary disorders (COPD), asthma, and sleep apnea among the population. In addition, the novel technological advancements and increasing application of respiratory devices in homecare settings are all expected to boost the market growth over the forecast period. For instance, as per a meta-analysis published by the Lung India journal in August 2022, it has been observed that the pooled prevalence of asthma was 7.9% among the Indian population.
- In addition, asthma was higher among boys (8%) than girls (5.9%). Furthermore, according to the World Health Organization (WHO), Tuberculosis (TB) statistics for India for 2021 estimated an incidence figure of 2.6 million cases. This is a rate of 188 per 100,000 population. Thus, the high burden of respiratory disease among the population is expected to increase the demand for respiratory monitoring, which is further anticipated to augment the segment.
- Additionally, the increasing initiatives, product launches, and strategies by market players in India are expected to contribute to the market's growth. For instance, in November 2021, Cipla Limited launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. Thus, owing to the above factors, the segment is expected to show a healthy growth rate over the forecast period. Thus, all aspects above are expected to boost the market in the country over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Asia-Pacific Respiratory Monitoring Industry Overview
The Asia-Pacific respiratory monitoring market is moderate due to the presence of companies operating regionally. The competitive landscape includes analyzing well-known companies holding market shares, including Medtronic, Draegerwerk, GE Healthcare, Philips, Resmed, Siemens Healthcare, and Teijin Pharma.
Asia-Pacific Respiratory Monitoring Market Leaders
-
Medtronic PLC
-
Dragerwerk AG & Co. KGaA
-
ResMed
-
GE Healthcare
-
Koninklijke Philips N.V
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Asia-Pacific Respiratory Monitoring Market News
- October 2022: AirPhysio partnered with Apollo Hospitals Group and Medsmart to launch its respiratory devices in India.
- April 2022: Sleepiz and SMS Hospital partnered to bring Sleepiz One+ to Ahmedabad, India. Sleepiz One+ monitors three critical vital signs of a patient - pulse rate, blood oxygen saturation, and respiration rate.
Asia-Pacific Respiratory Monitoring Industry Segmentation
As per the scope of the report, respiratory monitoring devices are used to monitor the patient's respiration rate. It can be used in hospitals and home care settings. Patches will be placed on the body to measure heart rate and respiration by transmitting real-time data with the help of leads attached to a monitor that displays and logs values for various time points. A monitor will be incorporated with an alarm to signal when the values are critically low, indicating a significant change in the patient's condition.
The Asia-Pacific respiratory monitoring market is segmented by type of device (spirometers, peak flow meters, sleep test devices, gas analyzers, pulse oximeters, capnographs, and other types of devices) and geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific).
The report offers the value (in USD) for the above segments.
| By Type of Device | Spirometers |
| Peak Flow Meters | |
| Sleep Test Devices | |
| Gas Analyzers | |
| Pulse Oximeters | |
| Capnographs | |
| Other Types of Devices | |
| Geography | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific |
Need A Different Region or Segment?
Customize Now
APAC Respiratory Monitoring Market Research FAQs
How big is the Asia-Pacific Respiratory Monitoring Market?
The Asia-Pacific Respiratory Monitoring Market size is expected to reach USD 1.04 billion in 2025 and grow at a CAGR of 9.73% to reach USD 1.66 billion by 2030.
What is the current Asia-Pacific Respiratory Monitoring Market size?
In 2025, the Asia-Pacific Respiratory Monitoring Market size is expected to reach USD 1.04 billion.
Who are the key players in Asia-Pacific Respiratory Monitoring Market?
Medtronic PLC, Dragerwerk AG & Co. KGaA, ResMed, GE Healthcare and Koninklijke Philips N.V are the major companies operating in the Asia-Pacific Respiratory Monitoring Market.
What years does this Asia-Pacific Respiratory Monitoring Market cover, and what was the market size in 2024?
In 2024, the Asia-Pacific Respiratory Monitoring Market size was estimated at USD 0.94 billion. The report covers the Asia-Pacific Respiratory Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Respiratory Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Asia-Pacific Respiratory Monitoring Industry Report
Statistics for the 2025 Asia-Pacific Respiratory Monitoring market share, size and revenue growth rate, created by Mordor Intelligenceâ„¢ Industry Reports. Asia-Pacific Respiratory Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
